Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple PDZ domain protein (MUPP1), also known as MPDZ, is a large scaffolding protein containing 13 PDZ domains that serves as a critical organizer of signaling complexes in various tissues [1.1.2, 1.3.1]. It is primarily localized to tight junctions in epithelial cells and postsynaptic densities in neurons, where it facilitates the assembly of multi-protein networks by binding to the C-termini of transmembrane receptors, ion channels, and adhesion molecules [1.2.5, 1.4.2]. MUPP1 interacts with a wide array of partners, including the 5-HT2C serotonin receptor, claudins, and CaMKII, thereby regulating cell polarity, paracellular permeability, and synaptic plasticity [1.1.2, 1.4.1, 1.4.3]. Mutations in the MPDZ gene are a known cause of autosomal recessive congenital hydrocephalus and have been linked to epilepsy and alcohol dependence [1.2.1, 1.2.2, 1.3.1]. Furthermore, MUPP1 is a cellular target for viral oncoproteins such as HPV E6 and Adenovirus E4-ORF1, which inactivate or degrade the protein to promote oncogenic transformation [1.1.1, 1.1.3]. While no approved drugs currently target MUPP1, it is being investigated as a therapeutic node for modulating opioid tolerance and as a potential target for peptide-based inhibitors of protein-protein interactions in cancer and neurological disorders [1.4.1, 1.5.2]. The protein's role in maintaining the blood-brain barrier and epithelial integrity makes it a complex but significant candidate for future drug development [1.2.5, 1.4.3].
Scaffolding and protein-protein interaction (PPI) modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple PDZ domain protein (MUPP1) (MUPP1).